1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 13 OCTOBER 2014

CNS Drug News 13 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Progressive MS Pipeline To See Increased Activity
Industry Brief - Bayer Comments On NICE Guideline Regarding MS Management
Industry Brief - Synthon Files Glatiramer ANDA With FDA
Industry Brief - FDA Grants Fast Track Designation To NurOwn For ALS
Industry Brief - Reata Initiates RTA 408 Phase II Studies In FA/Mitochondrial Myopathies
Industry Brief - Horizon Receives FDA ODD For Actimmune In FA
Industry Brief - Data Presented From Actimmune Phase II Study In FA
Industry Brief - StemCells Initiates Phase II Trial In Cervical SCI
Industry Brief - Stemedica Secures US Patent To Use Multiple SC Lines Simultaneously For Ischaemic Stroke
Industry Brief - NeurOp Receives Milestone As BMS Nominates Compound
Industry Brief - Alcobra Reports Top-Line Results From MDX Phase III Study In Adult ADHD
Industry Brief - Neos Issued Key Patent Covering XR-ODT Platform Technology
Industry Brief - Zogenix Submits sNDA For Modified Formulation Of Zohydro ER
Industry Trend Analysis - Teva Behind In Abuse-Deterrent Hydrocodone ER Race
Industry Brief - Purdue Commercially Launches New Dosage Strength Of Butrans
Industry Brief - Trevena Completes Enrolment Of TRV130 Phase IIa/b Study Ahead Of Schedule
Industry Brief - IntelGenx/RedHill Submit European MAA For Rizaport
Industry Brief - Eisai Names Partner For Pan Middle-East Distribution Of Fycompa
Industry Brief - New Generic Threat To Trokendi XR Revealed
Industry Brief - French Transparency Commission Recognises Efficacy Of Zonegran MT
Industry Brief - Supernus Files Topiramate Lawsuit Against Actavis
Industry Trend Analysis - Akynzeo To Compete With Merck's Emend In CINV Prevention
Industry Brief - Acacia Reports Positive Phase III Results For APD421 In PONV
Industry Trend Analysis - Teva Follows De-Diversification Trend With Focus On CNS/Respiratory
Industry Brief - CNS Conferences - January 2015

Table Of Contents

CNS Drug News 13 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.